Sanara MedTech Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Sanara MedTech's Board adopted an Insider Trading Policy on March 20, 2025, effective for all directors, officers, designated employees, and covered persons. The policy establishes trading blackout periods (14 days before quarter-end through 2 trading days after SEC filing), pre-clearance requirements for all insider trades, and prohibitions on short sales, margin accounts, options, and hedging transactions. This is a standard corporate governance document with no financial transactions, counterparties, or business developments.
Why this rating
Routine governance adoption; standard insider trading compliance policy with no business or financial impact. Administrative filing common at all public companies.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.